Veneno Technologies

About:

Veneno Technologies is a research and development of therapeutic disulfide-rich peptides and medicines.

Top Investors: SBI Investment, Tsukuba Institute of Research, SBI regional activation support Co., Ltd.

Description:

Veneno Technologies develops drug candidates for pharmaceutical companies. The company provides services that include the treatment of neurological, cardiovascular, and metabolic diseases, cancer cell proliferation, metastasis, and immune cell regulation.

Total Funding Amount:

200M JPY

Estimated Revenue Range:

$1M to $10M

Headquarters Location:

Tsukuba, Ibaraki, Japan

Founded Date:

2020-07-01

Contact Email:

info(AT)veneno.co.jp

Founders:

Number of Employees:

1-10

Last Funding Date:

2022-01-24

IPO Status:

Private

Industries: